These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8785973)

  • 21. [Attenuated acriflavin-fast Erysipelothrix insidiosa. Relationship between its capability to cause arthritis in mice and immunogenicity in swine].
    Seto K; Nishimura Y; Fujiki M; Azechi H; Suzuki K
    Nihon Juigaku Zasshi; 1971 Aug; 33(4):161-71. PubMed ID: 5106229
    [No Abstract]   [Full Text] [Related]  

  • 22. [Local antigen persistence and chronicity of experimental erysipelas polyarthritis].
    Denecke R; Trautwein G
    Berl Munch Tierarztl Wochenschr; 1986 Jun; 99(6):200-8. PubMed ID: 3741366
    [No Abstract]   [Full Text] [Related]  

  • 23. [On erysipelas immunization of pigs].
    Walzl HL; Hunyady G
    Schweiz Arch Tierheilkd; 1967 Mar; 109(3):150-7. PubMed ID: 5626729
    [No Abstract]   [Full Text] [Related]  

  • 24. [Aerogenic immunization against swine erysipelas with Spirovak erysipelas vaccine "Dessau"].
    Urbaneck D; Stöhr P; Michael-Meese M
    Arch Exp Veterinarmed; 1980; 34(1):51-4. PubMed ID: 7416893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Detection of Erysipelothrix rhusiopathiae specific antibodies in the serum of experimentally-infected swine by ELISA and immunoblotting].
    Dahms H; Schilow WF; Hagemann G
    Arch Exp Veterinarmed; 1989 Nov; 43(6):907-16. PubMed ID: 2619491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serological potency testing of vaccines against progressive atrophic rhinitis.
    Oppling V; Kusch M; Rübmann P; Cussler K
    Dev Biol Stand; 1996; 86():339. PubMed ID: 8785979
    [No Abstract]   [Full Text] [Related]  

  • 27. [Protective medium for the lyophilization of a live vaccine against swine erysipelas--VR2].
    Khristova Kh; Ninov NV; Dilovska Kh
    Vet Med Nauki; 1984; 21(7-8):57-61. PubMed ID: 6506460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Experiments on oral and aerogenic erysipelas immunization].
    Meese M; Möhlmann H; Stöhr P
    Monatsh Veterinarmed; 1968 May; 23(9):331-5. PubMed ID: 5692769
    [No Abstract]   [Full Text] [Related]  

  • 29. Induction of cross-protection in mice against dolphin Erysipelothrix rhusiopathiae isolates with a swine commercial vaccine.
    Lacave G; Cox E; Hermans J; Devriese L; Goddeeris BM
    Vet Microbiol; 2001 Jun; 80(3):247-53. PubMed ID: 11337140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [100 years of erysipelas prophylaxis: significance and reduction of animal experiments].
    Cussler K; Balks E
    ALTEX; 2001; 18(1):29-33. PubMed ID: 11248847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serotyping and pathogenicity of Erysipelothrix strains isolated from tonsils of slaughter pigs in Thailand.
    Takahashi T; Sunama P; Satra J; Cholsindhu N; Kongthon S; Jitnupong W; Yamamoto K; Kijima M; Furuuchi S
    J Vet Med Sci; 1999 Sep; 61(9):1007-11. PubMed ID: 10535518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erysipelas immunizing product review.
    Bairey MH; Vogel JH
    Proc Annu Meet U S Anim Health Assoc; 1973; (77):340-4. PubMed ID: 4534722
    [No Abstract]   [Full Text] [Related]  

  • 33. [On the histopathology of skin changes in experimental erysipelas infections in pigs. 3. Findings after intracutaneous injection of erysipelas haptens].
    Rudolph W
    Arch Exp Veterinarmed; 1967; 21(3):661-73. PubMed ID: 5628483
    [No Abstract]   [Full Text] [Related]  

  • 34. [Protein content in fodder and its effect on the immunity of pigs vaccinated against hog cholera, swine erysipelas and colibacteriosis].
    Wasińska B
    Med Weter; 1976 Dec; 32(12):722-7. PubMed ID: 797598
    [No Abstract]   [Full Text] [Related]  

  • 35. Etiological and biological characteristics of Erysipelothrix rhusiopathiae isolated between 1994 and 2001 from pigs with swine erysipelas in Japan.
    Ozawa M; Yamamoto K; Kojima A; Takagi M; Takahashi T
    J Vet Med Sci; 2009 Jun; 71(6):697-702. PubMed ID: 19578275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant properties of Propionibacterium avidum KP-40 in vaccination against endemic viral and bacterial infections. III. Swine immunized with live attenuated Erysipelothrix rhusiopathiae vaccine and experimentally infected with virulent strains R203 and R270B of E. rhusiopathiae.
    Markowska-Daniel I; Pejsak Z; Szmigielski S; Sokolska G; Jeljaszewicz J; Pulverer G
    Zentralbl Bakteriol; 1992 Dec; 277(4):547-53. PubMed ID: 1303697
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humane endpoints in the efficacy testing of swine erysipelas vaccines.
    Johannes S; Hartinger J; Hendriksen CF; Morton DB; Cussler K
    ALTEX; 2003; 20(1):11-5. PubMed ID: 12579350
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Swine abortion associated with use of live erysipelas vaccine.
    Henry S; Kelly B
    J Am Vet Med Assoc; 1979 Sep; 175(5):453-4. PubMed ID: 500477
    [No Abstract]   [Full Text] [Related]  

  • 39. Growth ability and immunological properties of Erysipelothrix rhusiopathiae serotype 2.
    Zarkasie K; Sawada T; Yoshida T; Takahashi I; Takahashi T
    J Vet Med Sci; 1996 Jan; 58(1):87-90. PubMed ID: 8645767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Intensity of antierysipelas immunity].
    Shcherbinin VK; Koniaev MT; Podlesnykh LA
    Veterinariia; 1977 Oct; (10):63-4. PubMed ID: 562557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.